GO:0007097 | nuclear migration | 3.14e-06 | 3.07e-02 | 9.347 | 2 | 2 | 5 |
GO:0051219 | phosphoprotein binding | 9.38e-05 | 9.16e-01 | 7.025 | 2 | 3 | 25 |
GO:0051081 | nuclear envelope disassembly | 6.14e-04 | 1.00e+00 | 10.668 | 1 | 1 | 1 |
GO:0090230 | regulation of centromere complex assembly | 6.14e-04 | 1.00e+00 | 10.668 | 1 | 1 | 1 |
GO:0000235 | astral microtubule | 6.14e-04 | 1.00e+00 | 10.668 | 1 | 1 | 1 |
GO:0051660 | establishment of centrosome localization | 6.14e-04 | 1.00e+00 | 10.668 | 1 | 1 | 1 |
GO:0031134 | sister chromatid biorientation | 6.14e-04 | 1.00e+00 | 10.668 | 1 | 1 | 1 |
GO:0036035 | osteoclast development | 6.14e-04 | 1.00e+00 | 10.668 | 1 | 1 | 1 |
GO:0046469 | platelet activating factor metabolic process | 6.14e-04 | 1.00e+00 | 10.668 | 1 | 1 | 1 |
GO:0035088 | establishment or maintenance of apical/basal cell polarity | 1.23e-03 | 1.00e+00 | 9.668 | 1 | 1 | 2 |
GO:0030036 | actin cytoskeleton organization | 1.23e-03 | 1.00e+00 | 5.177 | 2 | 2 | 90 |
GO:0051683 | establishment of Golgi localization | 1.23e-03 | 1.00e+00 | 9.668 | 1 | 1 | 2 |
GO:0071338 | positive regulation of hair follicle cell proliferation | 1.23e-03 | 1.00e+00 | 9.668 | 1 | 1 | 2 |
GO:0051835 | positive regulation of synapse structural plasticity | 1.23e-03 | 1.00e+00 | 9.668 | 1 | 1 | 2 |
GO:0090135 | actin filament branching | 1.23e-03 | 1.00e+00 | 9.668 | 1 | 1 | 2 |
GO:0034088 | maintenance of mitotic sister chromatid cohesion | 1.23e-03 | 1.00e+00 | 9.668 | 1 | 1 | 2 |
GO:0072384 | organelle transport along microtubule | 1.23e-03 | 1.00e+00 | 9.668 | 1 | 1 | 2 |
GO:0060661 | submandibular salivary gland formation | 1.23e-03 | 1.00e+00 | 9.668 | 1 | 1 | 2 |
GO:0045505 | dynein intermediate chain binding | 1.23e-03 | 1.00e+00 | 9.668 | 1 | 1 | 2 |
GO:0007070 | negative regulation of transcription from RNA polymerase II promoter during mitosis | 1.23e-03 | 1.00e+00 | 9.668 | 1 | 1 | 2 |
GO:0060684 | epithelial-mesenchymal cell signaling | 1.84e-03 | 1.00e+00 | 9.083 | 1 | 1 | 3 |
GO:0003161 | cardiac conduction system development | 1.84e-03 | 1.00e+00 | 9.083 | 1 | 1 | 3 |
GO:0071459 | protein localization to chromosome, centromeric region | 1.84e-03 | 1.00e+00 | 9.083 | 1 | 1 | 3 |
GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle | 1.84e-03 | 1.00e+00 | 9.083 | 1 | 1 | 3 |
GO:0021540 | corpus callosum morphogenesis | 1.84e-03 | 1.00e+00 | 9.083 | 1 | 1 | 3 |
GO:0008090 | retrograde axon cargo transport | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 4 |
GO:0030157 | pancreatic juice secretion | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 4 |
GO:0071922 | regulation of cohesin localization to chromatin | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 2 | 4 |
GO:0034191 | apolipoprotein A-I receptor binding | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 4 |
GO:0090136 | epithelial cell-cell adhesion | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 2 | 4 |
GO:0036336 | dendritic cell migration | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 4 |
GO:0048664 | neuron fate determination | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 4 |
GO:0043550 | regulation of lipid kinase activity | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 4 |
GO:0031256 | leading edge membrane | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 4 |
GO:0035189 | Rb-E2F complex | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 4 |
GO:0034349 | glial cell apoptotic process | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 4 |
GO:0001667 | ameboidal-type cell migration | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 4 |
GO:0048554 | positive regulation of metalloenzyme activity | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 4 |
GO:0031512 | motile primary cilium | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 5 |
GO:0031274 | positive regulation of pseudopodium assembly | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 5 |
GO:0003334 | keratinocyte development | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 5 |
GO:0048667 | cell morphogenesis involved in neuron differentiation | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 5 |
GO:0045842 | positive regulation of mitotic metaphase/anaphase transition | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 5 |
GO:0034452 | dynactin binding | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 5 |
GO:0031023 | microtubule organizing center organization | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 5 |
GO:0060789 | hair follicle placode formation | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 6 |
GO:0043353 | enucleate erythrocyte differentiation | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 6 |
GO:0001961 | positive regulation of cytokine-mediated signaling pathway | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 6 |
GO:0017145 | stem cell division | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 6 |
GO:0000075 | cell cycle checkpoint | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 6 |
GO:0005869 | dynactin complex | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 6 |
GO:0051489 | regulation of filopodium assembly | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 6 |
GO:0060047 | heart contraction | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 6 |
GO:0043497 | regulation of protein heterodimerization activity | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 6 |
GO:0051988 | regulation of attachment of spindle microtubules to kinetochore | 4.29e-03 | 1.00e+00 | 7.861 | 1 | 1 | 7 |
GO:0001675 | acrosome assembly | 4.29e-03 | 1.00e+00 | 7.861 | 1 | 1 | 7 |
GO:0032319 | regulation of Rho GTPase activity | 4.29e-03 | 1.00e+00 | 7.861 | 1 | 1 | 7 |
GO:0030126 | COPI vesicle coat | 4.29e-03 | 1.00e+00 | 7.861 | 1 | 1 | 7 |
GO:0021895 | cerebral cortex neuron differentiation | 4.29e-03 | 1.00e+00 | 7.861 | 1 | 1 | 7 |
GO:0043025 | neuronal cell body | 4.37e-03 | 1.00e+00 | 4.251 | 2 | 3 | 171 |
GO:0045502 | dynein binding | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 1 | 8 |
GO:0051233 | spindle midzone | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 1 | 8 |
GO:0097284 | hepatocyte apoptotic process | 5.52e-03 | 1.00e+00 | 7.499 | 1 | 1 | 9 |
GO:0031996 | thioesterase binding | 5.52e-03 | 1.00e+00 | 7.499 | 1 | 1 | 9 |
GO:0048854 | brain morphogenesis | 5.52e-03 | 1.00e+00 | 7.499 | 1 | 1 | 9 |
GO:0042551 | neuron maturation | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 10 |
GO:0045651 | positive regulation of macrophage differentiation | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 10 |
GO:0043488 | regulation of mRNA stability | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 10 |
GO:0009306 | protein secretion | 6.74e-03 | 1.00e+00 | 7.209 | 1 | 2 | 11 |
GO:0031333 | negative regulation of protein complex assembly | 6.74e-03 | 1.00e+00 | 7.209 | 1 | 1 | 11 |
GO:0045773 | positive regulation of axon extension | 6.74e-03 | 1.00e+00 | 7.209 | 1 | 1 | 11 |
GO:0030742 | GTP-dependent protein binding | 6.74e-03 | 1.00e+00 | 7.209 | 1 | 1 | 11 |
GO:0090316 | positive regulation of intracellular protein transport | 6.74e-03 | 1.00e+00 | 7.209 | 1 | 1 | 11 |
GO:0030225 | macrophage differentiation | 6.74e-03 | 1.00e+00 | 7.209 | 1 | 1 | 11 |
GO:0021819 | layer formation in cerebral cortex | 6.74e-03 | 1.00e+00 | 7.209 | 1 | 1 | 11 |
GO:0047496 | vesicle transport along microtubule | 6.74e-03 | 1.00e+00 | 7.209 | 1 | 1 | 11 |
GO:0005813 | centrosome | 6.95e-03 | 1.00e+00 | 3.907 | 2 | 6 | 217 |
GO:0007088 | regulation of mitosis | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 1 | 12 |
GO:0043274 | phospholipase binding | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 1 | 12 |
GO:0048205 | COPI coating of Golgi vesicle | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 1 | 12 |
GO:0000132 | establishment of mitotic spindle orientation | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 2 | 12 |
GO:0051146 | striated muscle cell differentiation | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 2 | 12 |
GO:0045445 | myoblast differentiation | 7.96e-03 | 1.00e+00 | 6.968 | 1 | 1 | 13 |
GO:0016514 | SWI/SNF complex | 7.96e-03 | 1.00e+00 | 6.968 | 1 | 1 | 13 |
GO:0019226 | transmission of nerve impulse | 7.96e-03 | 1.00e+00 | 6.968 | 1 | 1 | 13 |
GO:0046847 | filopodium assembly | 8.57e-03 | 1.00e+00 | 6.861 | 1 | 1 | 14 |
GO:0007405 | neuroblast proliferation | 8.57e-03 | 1.00e+00 | 6.861 | 1 | 1 | 14 |
GO:0042176 | regulation of protein catabolic process | 8.57e-03 | 1.00e+00 | 6.861 | 1 | 3 | 14 |
GO:0045859 | regulation of protein kinase activity | 8.57e-03 | 1.00e+00 | 6.861 | 1 | 1 | 14 |
GO:0070062 | extracellular vesicular exosome | 8.95e-03 | 1.00e+00 | 1.988 | 4 | 28 | 1641 |
GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 1 | 15 |
GO:0045879 | negative regulation of smoothened signaling pathway | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 1 | 15 |
GO:0051017 | actin filament bundle assembly | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 1 | 15 |
GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading | 9.79e-03 | 1.00e+00 | 6.668 | 1 | 1 | 16 |
GO:0032467 | positive regulation of cytokinesis | 9.79e-03 | 1.00e+00 | 6.668 | 1 | 1 | 16 |
GO:0007017 | microtubule-based process | 1.04e-02 | 1.00e+00 | 6.581 | 1 | 1 | 17 |
GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER | 1.04e-02 | 1.00e+00 | 6.581 | 1 | 1 | 17 |
GO:0031435 | mitogen-activated protein kinase kinase kinase binding | 1.10e-02 | 1.00e+00 | 6.499 | 1 | 1 | 18 |
GO:0031069 | hair follicle morphogenesis | 1.10e-02 | 1.00e+00 | 6.499 | 1 | 1 | 18 |
GO:0046329 | negative regulation of JNK cascade | 1.16e-02 | 1.00e+00 | 6.421 | 1 | 1 | 19 |
GO:0048565 | digestive tract development | 1.16e-02 | 1.00e+00 | 6.421 | 1 | 1 | 19 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 1.16e-02 | 1.00e+00 | 6.421 | 1 | 4 | 19 |
GO:0007163 | establishment or maintenance of cell polarity | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 2 | 20 |
GO:0005829 | cytosol | 1.22e-02 | 1.00e+00 | 1.865 | 4 | 33 | 1787 |
GO:0072686 | mitotic spindle | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 20 |
GO:0007346 | regulation of mitotic cell cycle | 1.28e-02 | 1.00e+00 | 6.276 | 1 | 1 | 21 |
GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle | 1.28e-02 | 1.00e+00 | 6.276 | 1 | 1 | 21 |
GO:0010977 | negative regulation of neuron projection development | 1.28e-02 | 1.00e+00 | 6.276 | 1 | 1 | 21 |
GO:0031647 | regulation of protein stability | 1.28e-02 | 1.00e+00 | 6.276 | 1 | 1 | 21 |
GO:0051149 | positive regulation of muscle cell differentiation | 1.34e-02 | 1.00e+00 | 6.209 | 1 | 2 | 22 |
GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity | 1.34e-02 | 1.00e+00 | 6.209 | 1 | 1 | 22 |
GO:0002040 | sprouting angiogenesis | 1.34e-02 | 1.00e+00 | 6.209 | 1 | 1 | 22 |
GO:0005875 | microtubule associated complex | 1.34e-02 | 1.00e+00 | 6.209 | 1 | 1 | 22 |
GO:0031424 | keratinization | 1.41e-02 | 1.00e+00 | 6.145 | 1 | 1 | 23 |
GO:0045931 | positive regulation of mitotic cell cycle | 1.41e-02 | 1.00e+00 | 6.145 | 1 | 2 | 23 |
GO:0000278 | mitotic cell cycle | 1.42e-02 | 1.00e+00 | 3.374 | 2 | 9 | 314 |
GO:0031252 | cell leading edge | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 2 | 24 |
GO:0007611 | learning or memory | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 1 | 24 |
GO:0007030 | Golgi organization | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 2 | 25 |
GO:0007093 | mitotic cell cycle checkpoint | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 2 | 25 |
GO:0003730 | mRNA 3'-UTR binding | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 1 | 25 |
GO:0034613 | cellular protein localization | 1.59e-02 | 1.00e+00 | 5.968 | 1 | 2 | 26 |
GO:0016042 | lipid catabolic process | 1.59e-02 | 1.00e+00 | 5.968 | 1 | 1 | 26 |
GO:0048471 | perinuclear region of cytoplasm | 1.69e-02 | 1.00e+00 | 3.242 | 2 | 7 | 344 |
GO:0034332 | adherens junction organization | 1.71e-02 | 1.00e+00 | 5.861 | 1 | 3 | 28 |
GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway | 1.71e-02 | 1.00e+00 | 5.861 | 1 | 2 | 28 |
GO:0050885 | neuromuscular process controlling balance | 1.71e-02 | 1.00e+00 | 5.861 | 1 | 1 | 28 |
GO:0042692 | muscle cell differentiation | 1.71e-02 | 1.00e+00 | 5.861 | 1 | 2 | 28 |
GO:0042802 | identical protein binding | 1.78e-02 | 1.00e+00 | 3.201 | 2 | 2 | 354 |
GO:0021987 | cerebral cortex development | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 1 | 30 |
GO:0051402 | neuron apoptotic process | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 1 | 30 |
GO:0050681 | androgen receptor binding | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 2 | 30 |
GO:0021766 | hippocampus development | 1.89e-02 | 1.00e+00 | 5.714 | 1 | 3 | 31 |
GO:0001102 | RNA polymerase II activating transcription factor binding | 1.89e-02 | 1.00e+00 | 5.714 | 1 | 1 | 31 |
GO:0005871 | kinesin complex | 1.89e-02 | 1.00e+00 | 5.714 | 1 | 1 | 31 |
GO:0045740 | positive regulation of DNA replication | 1.95e-02 | 1.00e+00 | 5.668 | 1 | 1 | 32 |
GO:0019900 | kinase binding | 1.95e-02 | 1.00e+00 | 5.668 | 1 | 2 | 32 |
GO:0008344 | adult locomotory behavior | 2.01e-02 | 1.00e+00 | 5.624 | 1 | 1 | 33 |
GO:0035914 | skeletal muscle cell differentiation | 2.01e-02 | 1.00e+00 | 5.624 | 1 | 1 | 33 |
GO:0021762 | substantia nigra development | 2.07e-02 | 1.00e+00 | 5.581 | 1 | 2 | 34 |
GO:0046330 | positive regulation of JNK cascade | 2.07e-02 | 1.00e+00 | 5.581 | 1 | 1 | 34 |
GO:0030521 | androgen receptor signaling pathway | 2.13e-02 | 1.00e+00 | 5.539 | 1 | 3 | 35 |
GO:0000226 | microtubule cytoskeleton organization | 2.19e-02 | 1.00e+00 | 5.499 | 1 | 1 | 36 |
GO:0030175 | filopodium | 2.25e-02 | 1.00e+00 | 5.459 | 1 | 2 | 37 |
GO:0050680 | negative regulation of epithelial cell proliferation | 2.37e-02 | 1.00e+00 | 5.383 | 1 | 1 | 39 |
GO:0043525 | positive regulation of neuron apoptotic process | 2.49e-02 | 1.00e+00 | 5.311 | 1 | 2 | 41 |
GO:0001047 | core promoter binding | 2.55e-02 | 1.00e+00 | 5.276 | 1 | 1 | 42 |
GO:0030141 | secretory granule | 2.67e-02 | 1.00e+00 | 5.209 | 1 | 2 | 44 |
GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity | 2.73e-02 | 1.00e+00 | 5.177 | 1 | 1 | 45 |
GO:0016020 | membrane | 2.82e-02 | 1.00e+00 | 2.016 | 3 | 25 | 1207 |
GO:0033138 | positive regulation of peptidyl-serine phosphorylation | 2.91e-02 | 1.00e+00 | 5.083 | 1 | 1 | 48 |
GO:0006469 | negative regulation of protein kinase activity | 3.03e-02 | 1.00e+00 | 5.025 | 1 | 1 | 50 |
GO:0060070 | canonical Wnt signaling pathway | 3.09e-02 | 1.00e+00 | 4.996 | 1 | 2 | 51 |
GO:0031295 | T cell costimulation | 3.09e-02 | 1.00e+00 | 4.996 | 1 | 1 | 51 |
GO:0045177 | apical part of cell | 3.27e-02 | 1.00e+00 | 4.914 | 1 | 1 | 54 |
GO:0035264 | multicellular organism growth | 3.27e-02 | 1.00e+00 | 4.914 | 1 | 1 | 54 |
GO:0000776 | kinetochore | 3.33e-02 | 1.00e+00 | 4.887 | 1 | 1 | 55 |
GO:0006338 | chromatin remodeling | 3.33e-02 | 1.00e+00 | 4.887 | 1 | 2 | 55 |
GO:0031175 | neuron projection development | 3.33e-02 | 1.00e+00 | 4.887 | 1 | 2 | 55 |
GO:0000785 | chromatin | 3.57e-02 | 1.00e+00 | 4.786 | 1 | 2 | 59 |
GO:0007265 | Ras protein signal transduction | 3.57e-02 | 1.00e+00 | 4.786 | 1 | 2 | 59 |
GO:0005179 | hormone activity | 3.63e-02 | 1.00e+00 | 4.762 | 1 | 1 | 60 |
GO:0010629 | negative regulation of gene expression | 3.75e-02 | 1.00e+00 | 4.714 | 1 | 2 | 62 |
GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II | 3.87e-02 | 1.00e+00 | 4.668 | 1 | 3 | 64 |
GO:0030426 | growth cone | 3.87e-02 | 1.00e+00 | 4.668 | 1 | 3 | 64 |
GO:0047485 | protein N-terminus binding | 3.93e-02 | 1.00e+00 | 4.646 | 1 | 1 | 65 |
GO:0001764 | neuron migration | 4.05e-02 | 1.00e+00 | 4.602 | 1 | 2 | 67 |
GO:0038096 | Fc-gamma receptor signaling pathway involved in phagocytosis | 4.23e-02 | 1.00e+00 | 4.539 | 1 | 3 | 70 |
GO:0030496 | midbody | 4.40e-02 | 1.00e+00 | 4.479 | 1 | 3 | 73 |
GO:0051056 | regulation of small GTPase mediated signal transduction | 4.58e-02 | 1.00e+00 | 4.421 | 1 | 1 | 76 |
GO:0005938 | cell cortex | 4.64e-02 | 1.00e+00 | 4.402 | 1 | 1 | 77 |
GO:0005815 | microtubule organizing center | 4.64e-02 | 1.00e+00 | 4.402 | 1 | 2 | 77 |
GO:0016605 | PML body | 4.76e-02 | 1.00e+00 | 4.365 | 1 | 1 | 79 |
GO:0005819 | spindle | 4.82e-02 | 1.00e+00 | 4.347 | 1 | 2 | 80 |
GO:0005737 | cytoplasm | 4.89e-02 | 1.00e+00 | 1.306 | 4 | 39 | 2633 |
GO:0005635 | nuclear envelope | 4.99e-02 | 1.00e+00 | 4.293 | 1 | 2 | 83 |
GO:0061024 | membrane organization | 5.35e-02 | 1.00e+00 | 4.193 | 1 | 3 | 89 |
GO:0006886 | intracellular protein transport | 5.35e-02 | 1.00e+00 | 4.193 | 1 | 1 | 89 |
GO:0008201 | heparin binding | 5.46e-02 | 1.00e+00 | 4.161 | 1 | 1 | 91 |
GO:0007050 | cell cycle arrest | 5.52e-02 | 1.00e+00 | 4.145 | 1 | 2 | 92 |
GO:0000086 | G2/M transition of mitotic cell cycle | 5.82e-02 | 1.00e+00 | 4.069 | 1 | 3 | 97 |
GO:0008017 | microtubule binding | 5.82e-02 | 1.00e+00 | 4.069 | 1 | 1 | 97 |
GO:0005198 | structural molecule activity | 6.05e-02 | 1.00e+00 | 4.010 | 1 | 1 | 101 |
GO:0005911 | cell-cell junction | 6.22e-02 | 1.00e+00 | 3.968 | 1 | 2 | 104 |
GO:0010628 | positive regulation of gene expression | 6.34e-02 | 1.00e+00 | 3.941 | 1 | 2 | 106 |
GO:0042981 | regulation of apoptotic process | 6.69e-02 | 1.00e+00 | 3.861 | 1 | 4 | 112 |
GO:0043005 | neuron projection | 6.75e-02 | 1.00e+00 | 3.848 | 1 | 2 | 113 |
GO:0003924 | GTPase activity | 7.09e-02 | 1.00e+00 | 3.774 | 1 | 3 | 119 |
GO:0000082 | G1/S transition of mitotic cell cycle | 7.44e-02 | 1.00e+00 | 3.703 | 1 | 6 | 125 |
GO:0030424 | axon | 7.61e-02 | 1.00e+00 | 3.668 | 1 | 4 | 128 |
GO:0031965 | nuclear membrane | 7.73e-02 | 1.00e+00 | 3.646 | 1 | 2 | 130 |
GO:0006184 | GTP catabolic process | 7.73e-02 | 1.00e+00 | 3.646 | 1 | 3 | 130 |
GO:0031625 | ubiquitin protein ligase binding | 8.19e-02 | 1.00e+00 | 3.560 | 1 | 2 | 138 |
GO:0007173 | epidermal growth factor receptor signaling pathway | 8.42e-02 | 1.00e+00 | 3.519 | 1 | 3 | 142 |
GO:0007067 | mitotic nuclear division | 9.72e-02 | 1.00e+00 | 3.302 | 1 | 5 | 165 |
GO:0007264 | small GTPase mediated signal transduction | 1.02e-01 | 1.00e+00 | 3.225 | 1 | 4 | 174 |
GO:0003713 | transcription coactivator activity | 1.08e-01 | 1.00e+00 | 3.145 | 1 | 3 | 184 |
GO:0005525 | GTP binding | 1.15e-01 | 1.00e+00 | 3.046 | 1 | 3 | 197 |
GO:0008134 | transcription factor binding | 1.22e-01 | 1.00e+00 | 2.961 | 1 | 5 | 209 |
GO:0007268 | synaptic transmission | 1.25e-01 | 1.00e+00 | 2.927 | 1 | 1 | 214 |
GO:0019901 | protein kinase binding | 1.34e-01 | 1.00e+00 | 2.810 | 1 | 8 | 232 |
GO:0007411 | axon guidance | 1.37e-01 | 1.00e+00 | 2.780 | 1 | 2 | 237 |
GO:0000139 | Golgi membrane | 1.53e-01 | 1.00e+00 | 2.608 | 1 | 4 | 267 |
GO:0005925 | focal adhesion | 1.61e-01 | 1.00e+00 | 2.529 | 1 | 12 | 282 |
GO:0045892 | negative regulation of transcription, DNA-templated | 1.80e-01 | 1.00e+00 | 2.360 | 1 | 1 | 317 |
GO:0007596 | blood coagulation | 1.91e-01 | 1.00e+00 | 2.263 | 1 | 4 | 339 |
GO:0045893 | positive regulation of transcription, DNA-templated | 2.10e-01 | 1.00e+00 | 2.110 | 1 | 6 | 377 |
GO:0005515 | protein binding | 2.11e-01 | 1.00e+00 | 0.659 | 4 | 50 | 4124 |
GO:0042803 | protein homodimerization activity | 2.36e-01 | 1.00e+00 | 1.927 | 1 | 4 | 428 |
GO:0016032 | viral process | 2.36e-01 | 1.00e+00 | 1.927 | 1 | 13 | 428 |
GO:0045087 | innate immune response | 2.48e-01 | 1.00e+00 | 1.848 | 1 | 6 | 452 |
GO:0005886 | plasma membrane | 3.02e-01 | 1.00e+00 | 0.868 | 2 | 13 | 1784 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 3.08e-01 | 1.00e+00 | 1.484 | 1 | 9 | 582 |
GO:0005634 | nucleus | 3.18e-01 | 1.00e+00 | 0.589 | 3 | 40 | 3246 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 3.36e-01 | 1.00e+00 | 1.338 | 1 | 8 | 644 |
GO:0005615 | extracellular space | 3.39e-01 | 1.00e+00 | 1.322 | 1 | 2 | 651 |
GO:0044822 | poly(A) RNA binding | 4.01e-01 | 1.00e+00 | 1.026 | 1 | 25 | 799 |
GO:0005654 | nucleoplasm | 4.31e-01 | 1.00e+00 | 0.894 | 1 | 16 | 876 |
GO:0003677 | DNA binding | 4.58e-01 | 1.00e+00 | 0.781 | 1 | 12 | 947 |
GO:0006351 | transcription, DNA-templated | 5.04e-01 | 1.00e+00 | 0.597 | 1 | 15 | 1076 |